It might be challenging to directly compare theresults and risk profiles of FDA-approved and compounded pharmaceuticals due to differences instrength, dose, and other factors
Referral pathways typically include general surgery consultation for symptomatic gallstones or cholecystitis, while suspected bile duct stones (choledocholithiasis) or cholangitis may require gastroenterology evaluation for possible endoscopic retrograde cholangiopancreatography (ERCP)
A notable clinical trial involving oral semaglutide ( Rybelsus ) showed substantial weight loss in participants over 68 weeks
Kordbacheh F, OMeara CH, Coupland LA, Lelliott PM, Parish CR
10.1111/dom.13218 41 KakuK.ArakiE.TanizawaY.Ross AgnerB.NishidaT.RantheM.et al (2019)
'WEIGHT LOSS IS A JOURNEY, NOT JUST A PILL' Dr